Kistler-Tiffany Companies’s Fulgent Genetics FLGT Stock Holding History

Kistler-Tiffany Companies’s Portfolio FLGT Stock Details FLGT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-89	Closed	-$2.65K	–	802
2022 Q4	$2.65K	Hold	89	–	–	﹤0.01%	719
2022 Q3	$3K	Hold	89	–	–	﹤0.01%	704
2022 Q2	$5K	Hold	89	–	–	﹤0.01%	662
2022 Q1	$6K	Hold	89	–	–	﹤0.01%	658
2021 Q4	$9K	Hold	89	–	–	﹤0.01%	603
2021 Q3	$8K	Hold	89	–	–	﹤0.01%	608
2021 Q2	$8K	Hold	89	–	–	﹤0.01%	589
2021 Q1	$9K	Hold	89	–	–	﹤0.01%	530
2020 Q4	$5K	Buy	+89	New	+$3.72K	﹤0.01%	549

Other funds holding FLGT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

DSCM

Divisadero Street Capital Management Miami, Florida $2.39B AUM 134.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Kistler-Tiffany Companies's FLGT Position: Q1 2023 in Review

Kistler-Tiffany Companies sold out of Fulgent Genetics (FLGT) in Q1 2023, closing a stake of 89 shares — an estimated $2.65K sold.

Kistler-Tiffany Companies first reported a position in FLGT in Q4 2020 and held it in 9 quarters. The position peaked at $9K in Q4 2021. 215 funds tracked by Wall St. Rank hold FLGT as of Q1 2023.

Kistler-Tiffany Companies reported no remaining Fulgent Genetics position as of Q1 2023 after selling out during the quarter.
Kistler-Tiffany Companies sold 89 Fulgent Genetics shares in Q1 2023, an estimated $2.65K.
Kistler-Tiffany Companies first reported a position in Fulgent Genetics in Q4 2020 and held it in 9 quarters.
Kistler-Tiffany Companies's Fulgent Genetics position peaked at $9K in Q4 2021.
215 funds tracked by Wall St. Rank held Fulgent Genetics as of Q1 2023.

Based on Kistler-Tiffany Companies's 13F filing for Q1 2023, filed 3 May 2023.